Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

  • Read more about Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

  • Read more about Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study

  • Read more about Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

  • Read more about Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

COVID-19 in PID Survey

  • Read more about COVID-19 in PID Survey

PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs

  • Read more about PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs

Northeast COVID-19 and Pregnancy Study Group

  • Read more about Northeast COVID-19 and Pregnancy Study Group

Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

  • Read more about Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns

  • Read more about Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns

"NORPLASMA" Covid-19 Convalescent Plasma Treatment Monitoring Study

  • Read more about "NORPLASMA" Covid-19 Convalescent Plasma Treatment Monitoring Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 241
  • Page 242
  • Page 243
  • Page 244
  • Current page 245
  • Page 246
  • Page 247
  • Page 248
  • Page 249
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA